Yuhan Corporation (KRX:000100)
105,700
+300 (0.28%)
Last updated: May 30, 2025
Yuhan Revenue
Yuhan had revenue of 491.56B KRW in the quarter ending March 31, 2025, with 10.56% growth. This brings the company's revenue in the last twelve months to 2.11T, up 13.66% year-over-year. In the year 2024, Yuhan had annual revenue of 2.07T with 11.23% growth.
Revenue (ttm)
2,114.76B
Revenue Growth
+13.66%
P/S Ratio
3.73
Revenue / Employee
1.04B
Employees
1,999
Market Cap
7,895.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,067.79B | 208.81B | 11.23% |
Dec 31, 2023 | 1,858.98B | 83.14B | 4.68% |
Dec 31, 2022 | 1,775.85B | 88.04B | 5.22% |
Dec 31, 2021 | 1,687.81B | 67.95B | 4.19% |
Dec 31, 2020 | 1,619.87B | 139.51B | 9.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
Peptron | 3.15B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 125.90B |